Table 3 Correlation of FAM99A expression with clinicopathologic features of patients in our HCC cohort.

Age (years)

1.033

0.309

 ≤ 50

30

13

17

 > 50

32

18

14

Gender

0.000

1.000

 Male

52

26

26

 Female

10

5

5

Liver cirrhosis

0.295

0.587

 Negative

20

11

9

 Positive

42

20

22

Hepatitis B virus infection

0.144

0.705

 Negative

8

3

5

 Positive

54

28

26

AFP level (ng/ml)

1.033

0.309

 ≤ 400

32

18

14

 > 400

30

13

17

Tumor size (cm)

3.161

0.075

 < 7

31

12

19

 ≥ 7

31

19

12

Tumor number

0.477

0.490

 Single

52

25

27

 Multiple

10

6

4

Microvascular invasion

4.168

0.041

 Negative

28

10

18

 Positive

34

21

13

Lymph nodes metastasis

0.000

1.000

 Negative

58

29

29

 Positive

4

2

2

Edmondson-Steiner grade

0.265

0.607

 I-II

26

12

14

 III-IV

36

19

17

BCLC stage

4.633

0.099

 A stage

31

12

19

 B stage

12

9

3

 C stage

19

10

9

Child-Pugh classification grade

0.000

1.000

 A

57

28

29

 B

5

3

2